These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma. Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921 [TBL] [Abstract][Full Text] [Related]
3. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366 [TBL] [Abstract][Full Text] [Related]
4. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742 [TBL] [Abstract][Full Text] [Related]
5. [ Parent EE; Patel D; Nye JA; Li Z; Olson JJ; Schuster DM; Goodman MM EJNMMI Res; 2020 Dec; 10(1):148. PubMed ID: 33284388 [TBL] [Abstract][Full Text] [Related]
6. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among Tomura N; Kokubun M; Saginoya T; Mizuno Y; Kikuchi Y AJNR Am J Neuroradiol; 2017 Aug; 38(8):1520-1527. PubMed ID: 28619837 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375 [TBL] [Abstract][Full Text] [Related]
8. Incidence of intracranial radiation necrosis following postoperative radiation therapy for sinonasal malignancies. Ahmad S; Le CH; Chiu AG; Chang EH Laryngoscope; 2016 Nov; 126(11):2445-2450. PubMed ID: 27296477 [TBL] [Abstract][Full Text] [Related]
10. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas. Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of positron-emission tomography textural indices for malignancy of 18F-fluorodeoxyglucose-avid adrenal lesions. Thuillier P; Bourhis D; Schick U; Alavi Z; Guezennec C; Robin P; Kerlan V; Salaun PY; Abgral R Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):79-87. PubMed ID: 30916534 [TBL] [Abstract][Full Text] [Related]
12. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531 [TBL] [Abstract][Full Text] [Related]
13. Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis. Travers S; Joshi K; Miller DC; Singh A; Nada A; Biedermann G; Cousins JP; Litofsky NS World Neurosurg; 2021 Jul; 151():e1059-e1068. PubMed ID: 34052453 [TBL] [Abstract][Full Text] [Related]
14. Determination of brain tumor recurrence using Yamaguchi S; Hirata K; Okamoto M; Shimosegawa E; Hatazawa J; Hirayama R; Kagawa N; Kishima H; Oriuchi N; Fujii M; Kobayashi K; Kobayashi H; Terasaka S; Nishijima KI; Kuge Y; Ito YM; Nishihara H; Tamaki N; Shiga T Cancer Sci; 2021 Oct; 112(10):4246-4256. PubMed ID: 34061417 [TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817 [TBL] [Abstract][Full Text] [Related]
16. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment. Minamimoto R; Saginoya T; Kondo C; Tomura N; Ito K; Matsuo Y; Matsunaga S; Shuto T; Akabane A; Miyata Y; Sakai S; Kubota K PLoS One; 2015; 10(7):e0132515. PubMed ID: 26167681 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis. Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251 [TBL] [Abstract][Full Text] [Related]